Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: planned admission for interventional pulmonary intervention major surgical or invasive procedure: r mainstem bronchus stent placement bronchoscopy x 2 history of present illness: 73 year old male initially presented in with weight loss and difficulty swallowing food. patient was found to have a mediatinal mass which was biopsied and came back as b cell lymphoma. pt had peg tube placed secondary to dysphagia and now takes almost all of his nutrition via peg. he was treated with chemotherapy with a combination of mitoxantrone, vincristine, cyclophosphamide, cortical steroids, and rituxan and following three treatments he transferred his care to the cancer center with dr. . he has subsequently completed 6 full cycles of chemotherapy and is now being considered for xrt. his last dose of chemotherapy was one month prior to admission at . despite the chemotherapy, the mediastinal mass has not improved and it was felt that perhaps the area could be rebiopsied to confirm diagnosis (as first biopsy done in ). . the patient has had intermittent episodes of dull chest pain in varied locations across his chest, radiating to his back when it is particularly severe, which became notably worse this past friday. no diaphoresis, radiation to jaw or arms, or nausea associated with the chest pain. he also has frequent episodes of nausea, with vomiting on an almost daily basis. otherwise he feels well. denies any cough or cold symptoms except for some very mild intermittent rhinorrhea, no fevers or cough; denies hematemesis, hemoptysis, brbpr, melana, or hematuria. he was admitted to on for planned ip stent given patient's increasing difficulty with breathing. he had the stent placed on and he reports his breathing feels much improved. past medical history: htn hypercholesterolemia 3.4 cm infrarenal aaa (pt denies this dx, will investigate) s/p clean cath in constipation s/p peg placement in social history: 1+ ppd/50 years but stopped in , hx of asbestos exposure (x 2 months) family history: father died from a stroke secondary to a brain aneurysm; mother unknown ca; no hx of lung disease physical exam: 97.3f tmax 97.7f hr 98 (79-99) bp 104/71 (91-122/12-71) rr 24 96/ra gen: elderly man in nad heent: perrla, eomi with + 3 beats r horizontal nystagmus, thick white coat on tongue and back of oropharynx cv: rrr, s1 s2 normal, no m/g/r lungs: decreased breath sounds on the l compared to the r, abdomen: soft, nt, nd, + bs ext: + 1 distal pulses, no edema neuro: alert, oriented, cn grossly intact pertinent results: 05:29pm glucose-191* urea n-9 creat-0.5 sodium-137 potassium-4.2 chloride-103 total co2-23 anion gap-15 05:29pm ck(cpk)-15* 05:29pm ck-mb-notdone ctropnt-<0.01 05:29pm calcium-9.6 phosphate-3.1 magnesium-1.9 05:29pm wbc-8.3 rbc-3.70* hgb-11.1* hct-32.9* mcv-89 mch-30.1 mchc-33.9 rdw-19.2* 05:29pm plt count-307 05:29pm pt-12.6 ptt-23.7 inr(pt)-1.1 ct trachea: large retrotracheal mediastinal mass compressing the right pulmonary artery, encasing the central left pulmonary veins and aorta, producing a high-grade stenosis in the left main bronchus and occulusion of the esophagus. mild atelectasis in the left lower lobe. small non-hemorrhagic left pleural effusion. coronary calcifications. right adrenal myolipoma ecg sinus rhythm low qrs voltages in limb leads left atrial abnormality no previous tracing available for comparison biopsy of l mainstem mass fna, left main stem mass: atypical lymphocytes suspicious for lymphoma. flow cytometry report : b cells demonstrate a monoclonal kappa light chain restricted population. they co-express pan-b cell markers cd19 (dim), 20 (dim), 22 along with cd10 (dim) fmc-7 (subset), hla-dr. do not express any other characteristic antigens including cd5. t cells express mature lineage antigens. immunophenotypic findings consistent with involvement by cd19+(dim)/cd20+(dim)/cd10+(dim), cd5 negative, monoclonal kappa (dim) b cell lymphoma. brief hospital course: 73 y.o. man with hx of htn, hyperlipidemia, infrarenal aaa, and posterior mediastinal mass with prior biopsy consistent with non-hodgkin's b cell lymphoma who presented to hospital for repeat biopsy, at which time he became acutely short of breath and was transferred to for a bronchial stent. 1) mediastinal mass: the patient has a large posterior mediastinal mass obstructing esophagus and now compressing bronchi and pulmonary vasculature. this was diagnosed as non-hodgkin's b cell lymphoma at outside hospital (). the patient is now s/p chemotherapy with no radiographic improvement. following admission, he underwent a left mainstem stent by the interventional pulmonary service on ; repeat bronchoscopy on showed that the stent was patent and there was no need for a right mainstem stent. the pathology was consistent with lymphoma (see attached report). he will follow-up with dr. for a repeat bronchoscopy and possible stent removal. at time of discharge, mr. ; he was provided with home oxygen for ambulation (given oxygen saturation 90% with ambulation). the patient will follow-up with his primary oncologist dr. and is scheduled for outpatient radiation therapy (starting monday ). 2) relative hypotension: the patient's blood pressures remained in the low 100s, possibly due to poor intake due to nausea or ivc compression from mediastinal mass. his amlodipne was held throughout his hospital course. his blood pressure should be closely monitored as an outpatient, as his pcp may need to restart anti-hypertensive agents. follow-up for his need to re-start. 3) code: dnr/dni medications on admission: norvasc 10 qd allopurinol 300 mg qd senokot 2 tabs q am ativan prn discharge medications: 1. allopurinol 300 mg tablet sig: one (1) tablet po daily (daily). 2. clotrimazole 10 mg troche sig: one (1) troche mucous membrane qid (4 times a day). disp:*40 troche(s)* refills:*0* 3. oxycodone-acetaminophen 5-325 mg/5 ml solution sig: 5-10 mls po q4-6h (every 4 to 6 hours) as needed for chest/back pain. disp:*100 ml(s)* refills:*0* 4. lansoprazole 30 mg susp,delayed release for recon sig: one (1) po daily (daily). disp:*30 unit* refills:*2* 5. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours). disp:*120 nebs* refills:*0* 6. ativan 1 mg tablet sig: one (1) tablet po every 4-6 hours as needed for anxiety/nausea. disp:*30 tablet(s)* refills:*0* 7. compazine 5 mg/5 ml syrup sig: ml po q 6 hours prn as needed for nausea. disp:*100 ml* refills:*0* 8. nebulizer machine for ipratropiun nebs 9. oxygen 2l nc, continuous discharge disposition: home with service facility: nursing services discharge diagnosis: primary: non-hodgkins lymphoma secondary: bronchial obstruction, hypoxemia, hypertension discharge condition: hemodynamically stable. discharge instructions: please take all medications as instructed. several changes were made to your medication regimen. please note changes on your medication list. if you experience any nausea, vomiting, lightheadedness, chest pain, shortness of breath, or any other concerning symptoms please seek medical attention immediately. followup instructions: please call the cancer center tomorrow to confirm your appointment with radiation oncology on monday, . tel. (. please follow-up with dr. within the next week. tel (. please follow-up with dr. as scheduled for a repeat bronchoscopy. md procedure: enteral infusion of concentrated nutritional substances other bronchoscopy other intubation of respiratory tract closed [endoscopic] biopsy of bronchus endoscopic excision or destruction of lesion or tissue of bronchus diagnoses: unspecified essential hypertension other and unspecified hyperlipidemia nausea alone hypoxemia reticulosarcoma, unspecified site, extranodal and solid organ sites other specified hypotension stricture and stenosis of esophagus obstructive chronic bronchitis without exacerbation anemia in neoplastic disease personal history of contact with and (suspected) exposure to asbestos 

Answer: The patient is high likely exposed to